Simona Capsoni Selected Research

Nervous System Diseases (Neurological Disorders)

1/2010

In the adult hippocampus, chronic nerve growth factor deprivation shifts GABAergic signaling from the hyperpolarizing to the depolarizing direction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Simona Capsoni Research Topics

Disease

28	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 09/2002
9	Pain (Aches) 01/2022 - 04/2009
9	Hereditary Sensory and Autonomic Neuropathies (HSAN) 01/2021 - 01/2010
6	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2021 - 03/2005
5	Memory Disorders (Memory Loss) 05/2021 - 03/2005
4	Cognitive Dysfunction 05/2021 - 03/2002
4	Inborn Genetic Diseases (Disease, Hereditary) 01/2021 - 01/2012
4	Alzheimer Disease 10 01/2014 - 01/2010
3	Intellectual Disability (Idiocy) 01/2021 - 02/2011
3	Amyloid Plaque 01/2014 - 09/2006
2	Dementia (Dementias) 06/2022 - 05/2021
2	Neuroinflammatory Diseases 05/2021 - 01/2021
2	Congenital Pain Insensitivity 01/2021 - 02/2014
2	Rare Diseases (Rare Disease) 12/2019 - 02/2011
1	Disease Progression 06/2022
1	Down Syndrome (Down's Syndrome) 01/2022
1	Demyelinating Diseases (Demyelinating Disease) 01/2021
1	Multiple Sclerosis 01/2021
1	Hyperalgesia 12/2019
1	Chronic Pain 12/2019
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2015
1	Ulcer 01/2015
1	Neuralgia (Stump Neuralgia) 02/2014
1	Hypohidrosis 02/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2012
1	Inflammation (Inflammations) 06/2011
1	Temporal Lobe Epilepsy 01/2010
1	Nervous System Diseases (Neurological Disorders) 01/2010
1	Amnesia (Dissociative Amnesia) 05/2004

Drug/Important Bio-Agent (IBA)

31	Nerve Growth Factor (NGF)IBA 01/2022 - 09/2002
9	Cholinergic Agents (Cholinergics)IBA 12/2019 - 03/2002
9	Amyloid (Amyloid Fibrils)IBA 01/2019 - 07/2006
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2010
7	Peptides (Polypeptides)IBA 01/2014 - 07/2006
5	Amyloid beta-PeptidesIBA 01/2010 - 09/2002
4	Nerve Growth Factors (Neurotrophins)IBA 05/2021 - 07/2010
3	AntibodiesIBA 01/2010 - 09/2002
2	ChloridesIBA 06/2022 - 01/2010
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2014 - 05/2004
2	sortilinIBA 02/2013 - 01/2013
1	SymportersIBA 06/2022
1	CationsIBA 06/2022
1	Bumetanide (Bumex)FDA LinkGeneric 06/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2021
1	ChemokinesIBA 01/2019
1	CytokinesIBA 01/2019
1	SynucleinsIBA 01/2018
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2014
1	Presenilin-1IBA 01/2013
1	Adenosine Triphosphate (ATP)IBA 04/2012
1	Adenosine Diphosphate (ADP)IBA 04/2012
1	Complement System Proteins (Complement)IBA 06/2011
1	trkA ReceptorIBA 02/2011
1	Biological ProductsIBA 02/2011
1	Biomarkers (Surrogate Marker)IBA 01/2011
1	Toxic ActionsIBA 09/2010
1	Flavin-Adenine Dinucleotide (FAD)IBA 09/2010
1	CHF 2819IBA 05/2004
1	Acetylcholine (Acetylcholine Chloride)FDA Link 05/2004
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 05/2004
1	ganstigmineIBA 05/2004
1	Scopolamine (Hyoscine)FDA Link 05/2004
1	Cholinergic AgonistsIBA 09/2002
1	Galantamine (Galanthamine)FDA LinkGeneric 09/2002

Therapy/Procedure

4	Therapeutics 01/2012 - 10/2008
2	Intranasal Administration 05/2021 - 03/2005